Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change

Trevi Therapeutics, Inc. (NASDAQ:TRVI) is one of the 12 best multibagger stocks to buy heading into 2026. Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change Copyright: djoronimo / 123RF Stock Photo On December 4, 2025, Trevi Therapeutics, Inc. (NASDAQ:TRVI) announced the appointment of David Hastings as Chief Financial Officer, effective January 6, 2026. This marks a key leadership change amid the company’s transition into a more advanced stage of development. As the company m ...